Parkinson's Disease
Parkinson’s disease can significantly affect movement and quality of life. At Apera Health Group, we provide personalized regenerative medicine programs supported by comprehensive medical evaluation, multidisciplinary expertise, and internationally accepted clinical protocols.
Parkinson’s Disease Stem Cell Treatment Planning Process
Initial Contact
Request for Medical Reports
Medical Assessment
Medical Assessment
1
2
3
4
Parkinson's Disease Care Journey:
Treatment Goal:
Our regenerative medicine approach aims to support neurological function and evaluate its potential impact on movement-related symptoms. Each treatment plan is personalized based on your condition, disease stage, and current medical therapy.
Expected Approach:
Treatment outcomes vary from person to person. Some patients may experience improvements in mobility, daily activities, or overall quality of life. These therapies are designed to complement your existing treatment, and any medication changes should only be made by your neurologist.
Who May Be Eligible?
Patients with a confirmed diagnosis of Parkinson’s disease who continue to experience movement-related symptoms despite medical treatment may be considered for evaluation. Eligibility is determined through a comprehensive review of neurological findings, medical history, imaging results, and overall health.
Candidate
Assessment
- Confirmed Parkinson's diagnosis
- Comprehensive medical evaluation
- Personalized treatment planning
Treatment Approach:
Comprehensive Neurological Assessment: Every patient undergoes a detailed neurological evaluation, including medical history, current symptoms, disease progression, and previous treatments. This assessment helps determine whether regenerative medicine may be appropriate as part of an individualized care plan.
Personalized Regenerative Medicine Plan: Following the evaluation, our multidisciplinary team develops a personalized treatment strategy based on the patient’s clinical condition, functional goals, and internationally accepted medical standards. Ongoing follow-up is included to monitor progress and support long-term care.
Recovery & Follow-up:
Post-Treatment Care: After the procedure, patients receive individualized follow-up recommendations based on their medical condition and treatment plan. Recovery experiences may vary from person to person, and our medical team provides ongoing guidance throughout the process.
Expected Outcomes: Responses to regenerative medicine are individual and may differ depending on factors such as diagnosis, disease stage, overall health, and treatment goals. While some patients may experience improvements in certain aspects of their condition, specific outcomes cannot be guaranteed. Regular follow-up appointments help monitor progress and support long-term care.
Who May Be Considered for Stem Cell Treatment in Parkinson’s Disease?
Patients with a confirmed diagnosis of Parkinson’s disease who continue to experience tremor, slowness of movement, muscle stiffness or significant motor fluctuations despite medication may be considered for a preliminary assessment of cellular and regenerative approaches. The stage of the disease, age, general health, current medications and neurological findings are reviewed together. Suitability is determined through an individual medical evaluation.
What Is the Aim of the Stem Cell Approach in Parkinson’s Disease?
The main aim of cellular treatment research is to support the function of dopamine-producing cells that are reduced in Parkinson’s disease and to evaluate possible effects on movement-related symptoms. Current scientific studies are focusing on whether dopaminergic cells developed from stem cells can survive in the brain and contribute to dopamine production.
Which Areas May Be Monitored After Treatment?
Depending on the patient’s condition, changes may be monitored in areas such as mobility, muscle stiffness, balance, daily activities and periods when medication becomes less effective. Because each patient may respond differently, treatment goals are defined according to the person’s existing symptoms and quality-of-life needs.
Will Current Parkinson’s Medications Be Discontinued?
A stem cell or regenerative approach does not automatically mean that existing Parkinson’s medications will be stopped. Whether medications should be continued or adjusted is determined by the neurologist. The treatment process is planned as part of a comprehensive care pathway and does not replace established neurological follow-up.
Which Documents Are Required for Preliminary Assessment?
The following documents are generally requested for a more accurate evaluation:
- A recent neurology report
- Parkinson’s diagnosis and medical history
- Names and dosages of current medications
- Brain MRI or other imaging results
- Information about previous treatments
- A summary of symptoms affecting daily life
After the records are reviewed, any additional tests and specialist consultations can be planned.
How Is the Treatment Process Organised in Türkiye?
Apera Health Group coordinates the process from the initial medical record review through specialist consultations, hospital planning, required tests, airport and hospital transfers, accommodation, interpreter support and post-treatment communication.
Patients and their families are informed about the planned stages before travelling to Türkiye, and a personalised pathway is prepared according to the medical assessment.
Does Stem Cell Treatment Completely Eliminate Parkinson’s Disease?
Cellular treatment research in Parkinson’s disease is a rapidly developing field with significant scientific potential. However, it is not currently considered a definitive standard treatment that produces the same result for every patient.
For this reason, the source and quality of the cellular product, production standards, method of administration and the patient’s individual medical suitability must be carefully evaluated.
How Can You Receive a Preliminary Assessment from Apera Health Group?
Your or your relative’s suitability for cellular and regenerative approaches in Parkinson’s disease can be evaluated after the medical records are reviewed by the Apera Health Group specialist team.
You may request a personalised preliminary assessment by sharing your neurology reports, recent test results and current medications. Our specialist team will explain the options that may be considered and the recommended next steps in your treatment pathway.
Request a Free Consultation
Schedule Your Free Consultation Today and Begin Your Journey to Health and Happiness
We are committed to protecting your privacy.
